Sentence examples for compounds that characterize from inspiring English sources

It reviews the complexity associated with insect colors extends, for pigments, to the sophisticated biochemistry with which insects make (and often recycle) the compounds that characterize their chemical colors and, for structural colors, to the production and control, often by single cells, of the precise cuticular architecture.

One promising new source of therapeutic agents has been discovered in plant secondary metabolites, irregularly occurring compounds that characterize certain plants or plant groups [ 4].

However, besides the IC50, there are many other types of information that characterize chemical compounds.

There are three general modes of binding that characterize the compound interactions with double-stranded DNA: intercalation, groove binding and covalent binding [ 92- 94].

We used the ChEMBL database (version 15) [ 44], from which we extracted compounds that are characterized as inhibitors or antagonists of our predicted targets as well as approved and experimental drugs.

A similar plate organization is used in the Diagramas de família (pp. 85 93), but without the extensive use of images that characterizes the compound leaf plates.

Inosilicate, formerly called Metasilicate, any of a class of inorganic compounds that have structures characterized by silicate tetrahedrons (a central silicon atom surrounded by four oxygen atoms at the corners of a tetrahedron) arranged in chains.

Coordination induced C N bond fusion synthetic protocol was successfully implemented for the synthesis of these compounds that are subsequently characterized using various spectroscopic techniques.

Nevertheless, acute toxicity testing might be a powerful tool in TIE, when applied to evaluate highly contaminated sites with acute toxicity caused by compounds that are well characterized [62].

Some compounds that have been characterized include Na2Np2O7, Na4NpO5, Na6NpO6, and Na2NpO4.

During our European Policy Workshop a representative of the European Medicines Agency EMAA) highlighted the shift that is taking place to biologically-derived medicinal product development, that is, to products based on compounds and cells derived from the human body instead of the conventional chemically-derived compounds that have come to characterize the pharmaceutical industry's product line.